While a previous report has suggested that loss of AIM1 could mediate a modest reduction in the viability of VCaP prostate cancer cells62, our data show that the major effect of AIM1 loss is a substantial increase in cell migration and invasiveness through increased cytoskeletal remodeling. The gene discussed is CRYBG1; the disease is prostate carcinoma.